BRONCHI-SHIELD
BRONCHI-SHIELD
Not authorised
- Bordetella bronchiseptica, strain 92 B, Live
Product identification
Medicine name:
BRONCHI-SHIELD
Versican Plus Bb IN Neusdruppels, lyofilisaat en oplosmiddel voor suspensie
Versican Plus Bb IN Lyophilisat et solvant pour suspension nasale en gouttes
Versican Plus Bb IN Lyophyllisat und Lösungsmittel zur Herstellung von Nasentropfen, Suspension
Active substance:
- Bordetella bronchiseptica, strain 92 B, Live
Target species:
-
Dog
Route of administration:
-
Nasal use
Product details
Active substance and strength:
-
Bordetella bronchiseptica, strain 92 B, Live2100000.00/Colony forming unit1.00Dose
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for nasal administration
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AE01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Belgium
Package description:
- Box containing 10 vials of 1 dose of lyophilisate and 10 vials of 1 dose of solvent and 10 cannulae for application
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
- Zoetis Belgium
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V277252
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0153/001
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
